Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali1 passage
• A review on the ethnomedicinal plants used for the traditional treatment of malaria in the Mayurbhanj district of Odisha, India1 passage
• A systematic review of transfusion-transmitted malaria in non-endemic areas1 passage
• Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial1 passage
• Analysis of the effect of primaquine dose on efficacy, safety, and tolerability in patients with Plasmodium vivax malaria in Ethiopia: a systematic review and individual patient data meta-analysis1 passage
• Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study1 passage
• Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria1 passage
• Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis1 passage
• Availability of malaria diagnostic tests, anti-malarial drugs, and the correctness of treatment: a systematic review and meta-analysis1 passage
• Bringing malaria diagnosis and treatment closer to the people: economic rationale for expanding malaria community case management to all ages in a rural district in Madagascar1 passage
• Clinical characteristics and outcome of malaria-associated acute kidney injury in adult patients: a systematic review and meta analysis1 passage
• Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications1 passage
• Delay in malaria care-seeking for children under five in Africa: a systematic review1 passage
• Determinants of delay in treatment-seeking among malaria patients attending health facilities in Ethiopia from 2010 to 2024: a systematic review and meta-analysis1 passage
• Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar1 passage
• Efficacy and safety of RTS, S and R21 malaria vaccines in children under five in Africa: a systematic review and meta-analysis of randomized controlled trials22 passages
• Efficacy and safety of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis1 passage
• Efficacy and safety of pyronaridine-artesunate versus artemether-lumefantrine in the treatment of acute uncomplicated malaria in children in South-West Nigeria: an open-labelled randomized controlled trial1 passage
• Efficacy of artemether-lumefantrine for uncomplicated plasmodium falciparum malaria treatment in mozambique: a systematic review and meta-analysis1 passage
• Efficacy of artemisinin-based combination therapy (ACT) in people living with HIV (PLHIV) diagnosed with uncomplicated Plasmodium falciparum malaria in Africa: a WWARN systematic review1 passage
• Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 20181 passage
• Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials1 passage
• Evidence of malarial chemoprophylaxis among travellers who died from malaria: a systematic review and meta-analysis1 passage
• Genetic diversity of Plasmodium falciparum and genetic profile in children affected by uncomplicated malaria in Cameroon1 passage
• Genetic diversity, population structure, and drug resistance of Plasmodium falciparum in Kenya: a systematic review and meta-analysis1 passage
• Global prevalence and mortality of severe Plasmodium malariae infection: a systematic review and meta-analysis1 passage
• How has mass drug administration with dihydroartemisinin-piperaquine impacted molecular markers of drug resistance? A systematic review1 passage
• Impact of a spatial repellent product on Anopheles and non-Anopheles mosquitoes in Sumba, Indonesia1 passage
• Implementation of post-discharge malaria chemoprevention (PDMC) in Benin, Kenya, Malawi, and Uganda: stakeholder engagement meeting report1 passage
• In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 20141 passage
• In vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo1 passage
• Increasing prevalence of malaria and acute dengue virus coinfection in Africa: a meta-analysis and meta-regression of cross-sectional studies1 passage
• Infant sex modifies associations between placental malaria and risk of malaria in infancy1 passage
• Intermittent screening using ultra-sensitive malaria rapid diagnostic test and treatment with pyronaridine-artesunate compared to standard preventive treatment with sulfadoxine-pyrimethamine for malaria prevention in pregnant women in Kinshasa, DRC1 passage
• Performance of rapid diagnostic tests for malaria diagnosis in Nigeria: a systematic review and meta-analysis1 passage
• Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine1 passage
• Plasma folate dynamics in Plasmodium falciparum-infected African children treated with artemisinin combination therapy and single low-dose primaquine or placebo1 passage
• Plasmodium falciparum gametocyte dynamics after pyronaridine-artesunate or artemether-lumefantrine treatment1 passage
• Population pharmacokinetics of fosmidomycin and clindamycin in combination with artesunate for uncomplicated Plasmodium falciparum malaria in Gabonese children and adults1 passage
• Predicting the risk of malaria re-introduction in countries certified malaria-free: a systematic review1 passage
• Prevalence of Plasmodium falciparum plasmepsin2/3 gene duplication in Africa and Asia: a systematic review and meta-analysis1 passage
• Prevalence of malaria and its major parasite species in Bangladesh: a systematic review and meta-analysis1 passage
• Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial1 passage
• Quantification of the misidentification of Plasmodium knowlesi as Plasmodium malariae by microscopy: an analysis of 1569 P. knowlesi cases1 passage
• Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers1 passage
• Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an aggregated data meta-analysis of randomized controlled trials1 passage
• Systematic analysis of direct antiglobulin test results in post-artesunate delayed haemolysis1 passage
• The effect of mefloquine dose on outcome of uncomplicated falciparum malaria treated with artesunate-mefloquine: a WWARN systematic review and individual patient data meta-analysis1 passage